IMS 2023 | Prevention & monitoring of infections in patients with multiple myeloma treated with immunotherapies
Joshua Richter
• 27 Sep 2023
In this video, Joshua Richter, MD, Mount Sinai Medical Center, New York City, NY, briefly discusses the monitoring and prevention of infections in patients with multiple myeloma being treated with immunotherapies, including CAR-T cells and bispecific antibodies. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consultant/advisor: Janssen, BMS, Pfizer, Karyopharm, Sanofi, Takeda, Abbvie, Genentech
Speakers bureau: Janssen, BMS, Sanofi, Adaptive Biotechnologies
